Balaxi Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Ashish Maheshwari
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7yrs |
| CEO ownership | n/a |
| Management average tenure | 4.3yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost
Feb 10
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet
Feb 09Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?
Aug 08The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested
May 20A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Feb 03Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Sep 06Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively
Jun 03Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 12Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 27
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -₹52m |
| Sep 30 2023 | n/a | n/a | -₹106m |
| Jun 30 2023 | n/a | n/a | -₹95m |
| Mar 31 2023 | n/a | n/a | ₹460m |
| Dec 31 2022 | n/a | n/a | ₹506m |
| Sep 30 2022 | n/a | n/a | ₹545m |
| Jun 30 2022 | n/a | n/a | ₹511m |
| Mar 31 2022 | ₹3m | ₹3m | ₹477m |
| Dec 31 2021 | n/a | n/a | ₹433m |
| Sep 30 2021 | n/a | n/a | ₹421m |
| Jun 30 2021 | n/a | n/a | ₹401m |
| Mar 31 2021 | ₹3m | ₹3m | ₹381m |
| Dec 31 2020 | n/a | n/a | ₹312m |
| Sep 30 2020 | n/a | n/a | ₹228m |
| Jun 30 2020 | n/a | n/a | ₹138m |
| Mar 31 2020 | ₹3m | ₹3m | ₹61m |
Compensation vs Market: Insufficient data to establish whether Ashish's total compensation is reasonable compared to companies of similar size in the Indian market.
Compensation vs Earnings: Ashish's compensation has increased whilst the company is unprofitable.
CEO
Ashish Maheshwari (53 yo)
7yrs
Tenure
₹3,250,000
Compensation
Mr. Ashish Maheshwari has been Managing Director and Executive Director of Balaxi Pharmaceuticals Limited (formerly known as Balaxi Ventures Limited) (formerly known as The Anandam Rubber Company Limited)...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Chairman | 7yrs | ₹3.25m | no data | |
| CFO & Financial Controller | 4.3yrs | no data | no data | |
| President Operations | no data | no data | no data | |
| Compliance Officer | no data | no data | no data | |
| Senior Vice President of Business Development | 4.3yrs | no data | no data | |
| Head of Alternate Channels | 4.3yrs | no data | no data | |
| Country Head of Angola | 4.3yrs | no data | no data | |
| Finance Controller of Angola | no data | no data | no data | |
| Head of Operations of Guatemala | no data | no data | no data | |
| Head of Operations of Dominician Republic | no data | no data | no data | |
| Compliance Head of Angola | no data | no data | no data | |
| Sales Head of Guatemala | no data | no data | no data |
4.3yrs
Average Tenure
Experienced Management: BALAXI's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Chairman | 7yrs | ₹3.25m | no data | |
| Independent Non-Executive Director | 7yrs | ₹300.00k | 2.03% ₹ 132.7m | |
| Non Executive Director | 7yrs | ₹2.05m | no data | |
| Independent Non-Executive Director | 7yrs | ₹250.00k | no data | |
| Independent Non-Executive Director | 3.7yrs | ₹250.00k | 0.49% ₹ 32.2m |
7.0yrs
Average Tenure
53yo
Average Age
Experienced Board: BALAXI's board of directors are considered experienced (7 years average tenure).